These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 14558327)

  • 1. [Pure red cell aplasia and antibodies against erythropoietin. Doubts still remain].
    Peces R
    Nefrologia; 2003; 23(4):295-6, 297. PubMed ID: 14558327
    [No Abstract]   [Full Text] [Related]  

  • 2. Antibody-mediated pure red cell aplasia due to epoetin alfa during antiviral therapy of chronic hepatitis C.
    Stravitz RT; Chung H; Sterling RK; Luketic VA; Sanyal AJ; Price AS; Purrington A; Shiffman ML
    Am J Gastroenterol; 2005 Jun; 100(6):1415-9. PubMed ID: 15929778
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Pure red blood cell aplasia associated with neutralizing antibodies against erythropoietin induced by epoetin alfa:a new form of acquired erythroblastopenia in auremic patients].
    Cases A; Esforzado N; Mas M; Ricart MJ; Cruzado JM
    Nefrologia; 2003; 23(3):266-70. PubMed ID: 12891943
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pure red cell aplasia with anti-erythropoietin antibodies occurs more commonly with one formulation of epoetin alfa than another.
    Macdougall IC
    Curr Med Res Opin; 2004 Jan; 20(1):83-6. PubMed ID: 14741076
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Erythropoietin-induced, antibody-mediated pure red cell aplasia.
    Rossert J;
    Eur J Clin Invest; 2005 Dec; 35 Suppl 3():95-9. PubMed ID: 16281965
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lesson learned from Eprex-associated pure red cell aplasia.
    Schellekens H
    Kidney Blood Press Res; 2007; 30 Suppl 1():9-12. PubMed ID: 17726337
    [No Abstract]   [Full Text] [Related]  

  • 7. Resolution of pure red cell aplasia with continued production of low titer anti-epoetin antibodies.
    Leikis MJ; Forbes IK; McMahon LP; Becker GJ
    Clin Nephrol; 2004 Dec; 62(6):481-2. PubMed ID: 15630912
    [No Abstract]   [Full Text] [Related]  

  • 8. [Unusual but serious adverse effect. Epoetin treatment of patients with kidney diseases caused erythroblastopenia].
    Stenvinkel P; Bárány P
    Lakartidningen; 2002 Oct; 99(42):4162-3. PubMed ID: 12448296
    [No Abstract]   [Full Text] [Related]  

  • 9. Epoetin-induced pure red cell aplasia: diagnosis and treatment.
    Macdougall IC
    Curr Opin Nephrol Hypertens; 2007 Nov; 16(6):585-8. PubMed ID: 18089975
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Drug-induced autoimmune red-cell aplasia.
    Bunn HF
    N Engl J Med; 2002 Feb; 346(7):522-3. PubMed ID: 11844855
    [No Abstract]   [Full Text] [Related]  

  • 11. Drug-induced and antibody-mediated pure red cell aplasia: a review of literature and current knowledge.
    Smalling R; Foote M; Molineux G; Swanson SJ; Elliott S
    Biotechnol Annu Rev; 2004; 10():237-50. PubMed ID: 15504708
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Re-challenging patients who developed pure red cell aplasia with epoetin: can it be done?
    Macdougall IC; Roche A; Rossert J; Casadevall N; Francois P; Kemeny DM
    Nephrol Dial Transplant; 2004 Nov; 19(11):2901-5. PubMed ID: 15496566
    [No Abstract]   [Full Text] [Related]  

  • 13. Two haemodialysis patients with epoetin alfa-induced pure red-cell aplasia recovered despite treatment with another epoetin preparation.
    Vartia A; Asola MR; Tertti R; Kunelius P; Metsärinne KP
    Nephrol Dial Transplant; 2004 May; 19(5):1313-6. PubMed ID: 15102972
    [No Abstract]   [Full Text] [Related]  

  • 14. Relationship between biopharmaceutical immunogenicity of epoetin alfa and pure red cell aplasia.
    Schellekens H
    Curr Med Res Opin; 2003; 19(5):433-4. PubMed ID: 13678481
    [No Abstract]   [Full Text] [Related]  

  • 15. Pure red-cell aplasia secondary to antierythropoietin antibodies.
    Guest SS; Levitt L
    N Engl J Med; 2003 Dec; 349(26):2572-3. PubMed ID: 14695426
    [No Abstract]   [Full Text] [Related]  

  • 16. Recommendations on haematological criteria for the diagnosis of epoetin-induced pure red cell aplasia.
    Casadevall N; Cournoyer D; Marsh J; Messner H; Pallister C; Parker-Williams J; Rossert J
    Eur J Haematol; 2004 Dec; 73(6):389-96. PubMed ID: 15522059
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Feasibility of a multiplex flow cytometric bead immunoassay for detection of anti-epoetin alfa antibodies.
    Ferbas J; Thomas J; Hodgson J; Gaur A; Casadevall N; Swanson SJ
    Clin Vaccine Immunol; 2007 Sep; 14(9):1165-72. PubMed ID: 17634512
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical characteristics of erythropoietin-associated pure red cell aplasia.
    Carson KR; Evens AM; Bennett CL; Luminari S
    Best Pract Res Clin Haematol; 2005; 18(3):467-72. PubMed ID: 15792921
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pure red cell aplasia induced by erythropoiesis-stimulating agents.
    Pollock C; Johnson DW; Hörl WH; Rossert J; Casadevall N; Schellekens H; Delage R; De Francisco A; Macdougall I; Thorpe R; Toffelmire E
    Clin J Am Soc Nephrol; 2008 Jan; 3(1):193-9. PubMed ID: 18178785
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Response to cyclosporine A in a patient with pure red cell aplasia due to antierythropoietin-alpha antibodies.
    Fraer M; Campbell A; Sawaya BP
    Semin Dial; 2006; 19(3):251-4. PubMed ID: 16689978
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.